{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:41:56Z","timestamp":1792813316825,"version":"4.5.0"},"reference-count":25,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j161","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T22:09:49Z","timestamp":1770847789000},"page":"31-43","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Myoferlin in Vesicle Trafficking and the Effects of Its Overexpression in Prostate Cancer"],"prefix":"10.1620","volume":"270","author":[{"given":"Yuki","family":"Katsumata","sequence":"first","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kawamorita","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Division of Cancer Stem Cells, Miyagi Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Tamai","sequence":"additional","affiliation":[{"name":"Division of Cancer Stem Cells, Miyagi Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, Institute of Development, Aging, and Cancer, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Urology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Blomme, A., Fahmy, K., Peulen, O., Costanza, B., Fontaine, M., Struman, I., Baiwir, D., de Pauw, E., Thiry, M., Bellahcene, A., Castronovo, V. &amp; Turtoi, A. (2016)  Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.  <i>Oncotarget<\/i>, 7, 83669-83683. https:\/\/doi.org\/10.18632\/oncotarget.13276","DOI":"10.18632\/oncotarget.13276"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Cornford, P., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A.M., der Kwast, T.H.V., Lam, T.B., et al. (2021)  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.  <i>Eur. Urol.<\/i>, 79, 263-282. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.046","DOI":"10.1016\/j.eururo.2020.09.046"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Cox, A., Zhao, C., Tolkach, Y., Nettersheim, D., Schmidt, D., Kristiansen, G., Mueller, S.C., Ritter, M., Hauser, S. &amp; Ellinger, J. (2020)  Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma.  <i>Anticancer Res.<\/i>, 40, 3119-3128. https:\/\/doi.org\/10.21873\/anticanres.14293","DOI":"10.21873\/anticanres.14293"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Dong, Y., Kang, H., Liu, H., Wang, J., Guo, Q., Song, C., Sun, Y., Zhang, Y., Zhang, H., Zhang, Z., Guan, H., Fang, Z. &amp; Li, F. (2019)  Myoferlin, a Membrane Protein with Emerging Oncogenic Roles.  <i>Biomed. Res. Int.<\/i>, 2019, 7365913. https:\/\/doi.org\/10.1155\/2019\/7365913","DOI":"10.1155\/2019\/7365913"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Gu, H., Peng, Y. &amp; Chen, Y. (2020)  An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors.  <i>Curr. Top. Med. Chem.<\/i>, 20, 1509-1515. https:\/\/doi.org\/10.2174\/1568026620666200618123436","DOI":"10.2174\/1568026620666200618123436"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gupta, S., Yano, J., Mercier, V., Htwe, H.H., Shin, H.R., Rademaker, G., Cakir, Z., Ituarte, T., Wen, K.W., Kim, G.E., Zoncu, R., Roux, A., Dawson, D.W. &amp; Perera, R.M. (2021)  Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth.  <i>Nat. Cell Biol.<\/i>, 23, 232-242. https:\/\/doi.org\/10.1038\/s41556-021-00644-7","DOI":"10.1038\/s41556-021-00644-7"},{"key":"7","doi-asserted-by":"publisher","unstructured":"He, Y., Kan, W., Li, Y., Hao, Y., Huang, A., Gu, H., Wang, M., Wang, Q., Chen, J., Sun, Z., Liu, M., Chen, Y. &amp; Yi, Z. (2021)  A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression.  <i>Clin. Transl. Med.<\/i>, 11, e289. https:\/\/doi.org\/10.1002\/ctm2.289","DOI":"10.1002\/ctm2.289"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Jung, M., Lee, C., Park, J.H. &amp; Moon, K.C. (2019)  Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.  <i>Urol. Oncol.<\/i>, 37, 812 e819-812 e816. https:\/\/doi.org\/10.1016\/j.urolonc.2019.07.002","DOI":"10.1016\/j.urolonc.2019.07.002"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Kirkegaard, T. &amp; Jaattela, M. (2009)  Lysosomal involvement in cell death and cancer.  <i>Biochim. Biophys. Acta<\/i>, 1793, 746-754. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.09.008","DOI":"10.1016\/j.bbamcr.2008.09.008"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Liu, K.C., Huang, A.C., Wu, P.P., Lin, H.Y., Chueh, F.S., Yang, J.S., Lu, C.C., Chiang, J.H., Meng, M. &amp; Chung, J.G. (2011)  Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.  <i>Oncol. Rep.<\/i>, 26, 177-184. https:\/\/doi.org\/10.3892\/or.2011.1264","DOI":"10.3892\/or.2011.1264"},{"key":"11","doi-asserted-by":"publisher","unstructured":"Liu, Z., Jin, Q., Yan, T., Wo, Y., Liu, H. &amp; Wang, Y. (2022)  Exosome-mediated transduction of mechanical force regulates prostate cancer migration via microRNA.  <i>Biochem. Biophys. Rep.<\/i>, 31, 101299. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101299","DOI":"10.1016\/j.bbrep.2022.101299"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Mashouri, L., Yousefi, H., Aref, A.R., Ahadi, A.M., Molaei, F. &amp; Alahari, S.K. (2019)  Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.  <i>Mol. Cancer<\/i>, 18, 75. https:\/\/doi.org\/10.1186\/s12943-019-0991-5","DOI":"10.1186\/s12943-019-0991-5"},{"key":"13","doi-asserted-by":"publisher","unstructured":"Mottet, N., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A.M., van der Kwast, T.H., Lam, T.B., et al. (2021)  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.  <i>Eur. Urol.<\/i>, 79, 243-262. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042","DOI":"10.1016\/j.eururo.2020.09.042"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Pal, S., Ganguly, K.K. &amp; Chatterjee, A. (2013)  Extracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3.  <i>Cell Commun. Adhes.<\/i>, 20, 105-114. https:\/\/doi.org\/10.3109\/15419061.2013.833193","DOI":"10.3109\/15419061.2013.833193"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Rademaker, G., Hennequiere, V., Brohee, L., Nokin, M.J., Lovinfosse, P., Durieux, F., Gofflot, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., et al. (2018)  Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.  <i>Oncogene<\/i>, 37, 4398-4412. https:\/\/doi.org\/10.1038\/s41388-018-0287-z","DOI":"10.1038\/s41388-018-0287-z"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Redpath, G.M., Sophocleous, R.A., Turnbull, L., Whitchurch, C.B. &amp; Cooper, S.T. (2016)  Ferlins Show Tissue-Specific Expression and Segregate as Plasma Membrane\/Late Endosomal or Trans-Golgi\/Recycling Ferlins.  <i>Traffic<\/i>, 17, 245-266. https:\/\/doi.org\/10.1111\/tra.12370","DOI":"10.1111\/tra.12370"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Shah, T., Wildes, F., Kakkad, S., Artemov, D. &amp; Bhujwalla, Z.M. (2016)  Lymphatic endothelial cells actively regulate prostate cancer cell invasion.  <i>NMR Biomed.<\/i>, 29, 904-911. https:\/\/doi.org\/10.1002\/nbm.3543","DOI":"10.1002\/nbm.3543"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. &amp; Bray, F. (2021)  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.  <i>CA Cancer J. Clin.<\/i>, 71, 209-249. https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Turtoi, A., Blomme, A., Bellahcene, A., Gilles, C., Hennequiere, V., Peixoto, P., Bianchi, E., Noel, A., De Pauw, E., Lifrange, E., Delvenne, P. &amp; Castronovo, V. (2013)  Myoferlin is a key regulator of EGFR activity in breast cancer.  <i>Cancer Res.<\/i>, 73, 5438-5448. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1142","DOI":"10.1158\/0008-5472.CAN-13-1142"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Vlaeminck-Guillem, V. (2022)  Exosomes and prostate cancer management.  <i>Semin. Cancer Biol.<\/i>, 86, 101-111. https:\/\/doi.org\/10.1016\/j.semcancer.2021.08.004","DOI":"10.1016\/j.semcancer.2021.08.004"},{"key":"21","doi-asserted-by":"publisher","unstructured":"Yoshida, S., Hasegawa, T., Suzuki, M., Sugeno, N., Kobayashi, J., Ueyama, M., Fukuda, M., Ido-Fujibayashi, A., Sekiguchi, K., Ezura, M., Kikuchi, A., Baba, T., Takeda, A., Mochizuki, H., Nagai, Y., et al. (2018)  Parkinson\u2019s disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking.  <i>Hum. Mol. Genet.<\/i>, 27, 823-836. https:\/\/doi.org\/10.1093\/hmg\/ddy003","DOI":"10.1093\/hmg\/ddy003"},{"key":"22","doi-asserted-by":"publisher","unstructured":"Zhang, T., Li, J., He, Y., Yang, F., Hao, Y., Jin, W., Wu, J., Sun, Z., Li, Y., Chen, Y., Yi, Z. &amp; Liu, M. (2018a)  A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer.  <i>Nat. Commun.<\/i>, 9, 3726. https:\/\/doi.org\/10.1038\/s41467-018-06179-0","DOI":"10.1038\/s41467-018-06179-0"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Zhang, W., Zhou, P., Meng, A., Zhang, R. &amp; Zhou, Y. (2018b)  Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.  <i>J. Cell. Mol. Med.<\/i>, 22, 1743-1754. https:\/\/doi.org\/10.1111\/jcmm.13455","DOI":"10.1111\/jcmm.13455"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Zhu, W., Zhou, B., Zhao, C., Ba, Z., Xu, H., Yan, X., Liu, W., Zhu, B., Wang, L. &amp; Ren, C. (2019)  Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.  <i>J. Cell. Mol. Med.<\/i>, 23, 7180-7189. https:\/\/doi.org\/10.1111\/jcmm.14648","DOI":"10.1111\/jcmm.14648"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Zhu, X., Zhuo, Y., Wu, S., Chen, Y., Ye, J., Deng, Y., Feng, Y., Liu, R., Cai, S., Zou, Z., Wang, B., Wu, C.L., Zeng, G. &amp; Zhong, W. (2021)  TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis.  <i>Front. Oncol.<\/i>, 11, 632524. https:\/\/doi.org\/10.3389\/fonc.2021.632524","DOI":"10.3389\/fonc.2021.632524"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/270\/1\/270_2025.J161\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:26:58Z","timestamp":1792812418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/270\/1\/270_2025.J161\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j161","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J161"}}